Can you provide a detailed account of continuous positive airway pressure (CPAP), high‑flow nasal cannula (HFNC), and triage in neonatal respiratory distress syndrome?

Respiratory Support in Neonatal Respiratory Distress Syndrome: CPAP, HFNC, and Triage

For spontaneously breathing preterm infants with respiratory distress syndrome requiring respiratory support in the delivery room, initiate CPAP rather than intubation and mechanical ventilation. 1

Initial Triage and Assessment

When a neonate presents with respiratory distress (labored breathing, grunting, retractions, persistent cyanosis), immediately assess:

• Gestational age: Critical determinant of management strategy
• Spontaneous breathing effort: Distinguishes between need for positive pressure ventilation versus continuous positive airway pressure
• Severity of distress: Determines urgency and initial support level
• Oxygen saturation: Guide supplemental oxygen needs

CPAP: First-Line Respiratory Support

Evidence-Based Recommendations by Gestational Age

Preterm Infants (<37 weeks):

• CPAP is superior to intubation for spontaneously breathing preterm infants with respiratory distress 1
• Reduces death or bronchopulmonary dysplasia compared to mechanical ventilation 1
• Decreases need for mechanical ventilation without affecting neurodevelopmental outcomes at 18-22 months 1
• Apply within the first 15 minutes of life for maximum benefit 1

Term and Late Preterm Infants (≥37 weeks):

• Insufficient evidence to recommend routine CPAP use 1
• May consider avoiding CPAP in infants with mild respiratory distress (grunting, retractions, tachypnea) whose oxygen saturations are reaching target ranges 1

CPAP Implementation Details

Settings:

• Initial pressure: 5-8 cm H₂O 2
• Delivery via nasal prongs or mask
• Use T-piece resuscitator when available (preferred over self-inflating bag) 1

Mechanism of Action:

• Prevents atelectasis by maintaining functional residual capacity 2
• Particularly beneficial for surfactant-deficient lungs in preterm infants
• Less invasive than intubation, avoiding complications of mechanical ventilation

CPAP with Selective Surfactant Strategy

This approach is now standard of care for very preterm infants:

• Start CPAP immediately after birth
• Administer surfactant selectively only if respiratory distress worsens
• This strategy reduces bronchopulmonary dysplasia and death compared to prophylactic intubation with surfactant 3, 4, 5

High-Flow Nasal Cannula (HFNC): Limited Role

Primary Respiratory Support

HFNC is INFERIOR to CPAP as primary support and should not be used as first-line therapy for neonatal RDS 6, 7:

• Treatment failure rate significantly higher with HFNC versus CPAP (26.3% vs 7.9%, p<0.001) 6
• Meta-analysis confirms higher failure rate (RR=1.86,95% CI: 1.53-2.25) 7
• Not recommended for primary respiratory support in RDS 7

Post-Extubation Support

HFNC may be acceptable after extubation in select circumstances:

• For infants ≥28 weeks gestation in the weaning phase 7
• Comparable efficacy to CPAP for post-extubation support 8, 7
• Lower incidence of nasal trauma compared to CPAP 7
• No difference in reintubation rates 7

Hemodynamic Considerations

Both HFNC and CPAP cause reversible reduction in mesenteric blood flow but do not significantly impact cardiac or cerebral hemodynamics 9. This effect resolves upon discontinuation and should not preclude their use in hemodynamically stable infants.

Clinical Algorithm for Respiratory Support

Step 1: Delivery Room Assessment

• Preterm infant with spontaneous breathing + respiratory distress → Start CPAP immediately (within 15 minutes)
• Preterm infant without spontaneous breathing or severe bradycardia → Positive pressure ventilation with PEEP

Step 2: CPAP Trial (First 72 Hours)

• Continue CPAP at 5-8 cm H₂O
• Monitor for treatment failure indicators:
  • Persistent hypoxemia despite FiO₂ >0.40
  • Severe or increasing work of breathing
  • Apnea requiring intervention
  • Respiratory acidosis (pH <7.20, pCO₂ >65 mmHg)

Step 3: CPAP Failure Management

• Administer surfactant via INSURE technique (INtubation-SURfactant-Extubation)
• Return to CPAP after surfactant
• If persistent failure → mechanical ventilation

Step 4: Weaning Phase

• Once stable on CPAP with improving respiratory status
• May transition to HFNC for infants ≥28 weeks gestation
• Do not use HFNC as step-down for extremely preterm infants (<28 weeks)

Critical Pitfalls to Avoid

1. Do not use HFNC as primary support for RDS - significantly higher failure rates than CPAP 6, 7

2. Do not delay CPAP initiation - apply within first 15 minutes for preterm infants to maximize benefit 1

3. Do not routinely intubate for prophylactic surfactant - CPAP with selective surfactant reduces bronchopulmonary dysplasia 1, 3, 5

4. Do not use CPAP routinely in term infants with mild distress - insufficient evidence and may cause unnecessary intervention 1

5. Ensure backup equipment availability - have self-inflating bag ready if using T-piece resuscitator (gas supply failure risk) 1

6. Monitor for pneumothorax - CPAP increases risk compared to mechanical ventilation (9% vs 3%) 5

Adjunctive Measures

PEEP During Positive Pressure Ventilation:

• Use PEEP (5 cm H₂O) for premature infants requiring PPV during resuscitation 2
• Prevents lung collapse, maintains functional residual capacity
• Insufficient data for term infants 2

Surfactant Administration:

• Early rescue surfactant (<2 hours) reduces mortality and air leak in preterm infants 3, 4
• Animal-derived surfactants are effective 3, 4
• Administer via brief intubation then return to CPAP 8

Antenatal Steroids:

• Significantly reduce RDS severity, mortality, and surfactant need 3, 4
• Most effective between 28-34 weeks gestation 3
• Do not eliminate need for CPAP in extremely preterm infants (<27 weeks) 3